PubRank

Lisa Patterson

Author PubWeight™ 20.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res 2007 3.09
2 NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res 2008 2.76
3 Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 2012 2.70
4 Practice management guidelines for the evaluation of blunt abdominal trauma: the East practice management guidelines work group. J Trauma 2002 1.87
5 Factors associated with survival following blunt chest trauma in older patients: results from a large regional trauma cooperative. Arch Surg 2010 1.53
6 Managing conflicts of interest in clinical care: a national survey of policies at U.S. medical schools. Acad Med 2011 1.42
7 A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol Pharmacol 2002 1.33
8 Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res 2007 1.14
9 Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis. Mol Cancer Ther 2006 1.10
10 In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors. Cancer Res 2007 1.07
11 Angiogenic functions of voltage-gated Na+ Channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling. J Biol Chem 2011 1.04
12 Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. Int J Cancer 2002 0.85
13 In vitro assays for endothelial cell functions related to angiogenesis: proliferation, motility, tubular differentiation, and proteolysis. Methods Mol Biol 2009 0.84
14 The identification of novel PLC-gamma inhibitors using virtual high throughput screening. Bioorg Med Chem 2009 0.80
15 Toeing the line. With added scrutiny, vendors heeding physician marketing rules. Mod Healthc 2008 0.75
16 Isolated traumatic disruption of the ureteropelvic junction in a patient with a solitary kidney. J Trauma 2002 0.75
17 Placental abruption. J Trauma 2002 0.75
18 Car-surfing in southwest Ohio: incidence and injuries. J Trauma 2005 0.75
19 Interventional options for malignant upper gastrointestinal obstruction. J Palliat Med 2005 0.75